2017
DOI: 10.1111/petr.13027
|View full text |Cite
|
Sign up to set email alerts
|

Assessing barriers to adherence in routine clinical care for pediatric kidney transplant patients

Abstract: Patient-identified barriers to immunosuppressive medications are associated with poor adherence and negative clinical outcomes in transplant patients. Assessment of adherence barriers is not part of routine post-transplant care, and studies regarding implementing such a process in a reliable way are lacking. Using the Model for Improvement and PDSA cycles, we implemented a system to identify adherence barriers, including patient-centered design of a barriers assessment tool, identification of eligible patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
41
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 35 publications
(44 citation statements)
references
References 32 publications
2
41
1
Order By: Relevance
“…Indeed, once nonadherence is correctly identified, the next step is to develop interventions to address barriers to adherence with the goal of ultimately improving adherence. There is existing literature focused on the need for a multidisciplinary team to intervene and address barriers to adherence in real time [33]; however, little to no successful interventions for patients with CKD exist and therefore more study is needed. We suggest that both a multimethod approach to identifying nonadherence and a multimethod approach to addressing nonadherence is essential to improving medication adherence in patients with chronic disease, such as CKD.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, once nonadherence is correctly identified, the next step is to develop interventions to address barriers to adherence with the goal of ultimately improving adherence. There is existing literature focused on the need for a multidisciplinary team to intervene and address barriers to adherence in real time [33]; however, little to no successful interventions for patients with CKD exist and therefore more study is needed. We suggest that both a multimethod approach to identifying nonadherence and a multimethod approach to addressing nonadherence is essential to improving medication adherence in patients with chronic disease, such as CKD.…”
Section: Discussionmentioning
confidence: 99%
“…Cochrane Collaboration’s evaluation tool was used to assess the quality of clinical trials 26. This tool evaluates6 areas including random sequence generation, allocation concealment, blinding participants and personnel, blinding outcome assessor, incomplete outcomes data, and selective outcome reporting. The first and second items are to prevent selection bias, while others are designed to prevent performance bias, detection bias, attrition bias, and reporting bias, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…Quasi-experimental studies were assessed by using the Quality Assessment Tool for Pre- and Post-Intervention Designs by Brown et al, which is adopted from Estabrooks et al27,28 This tool evaluates6 areas including sampling, design, control of confounders, data collection and outcome measurement, statistical analysis, and conclusions and dropouts. Each study was evaluated independently by the two reviewers (RG, MRMH), and a consensus was reached on the disagreements by holding a bilateral discussion.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…These types of programs may be even more effective if employed in smartphones. For example, in pediatric kidney transplantation, Varnell and colleagues created an electronic health record‐enabled questionnaire to track adherence barriers than can flag patients appropriate for intervention as well as inform what types of intervention might be most successful …”
Section: Behavior Change and Patient Readinessmentioning
confidence: 99%